Skip Navigation

Cardiovascular Research 2004 62(3):538-547; doi:10.1016/j.cardiores.2004.01.038
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Díaz, M.E
Right arrow Articles by Trafford, A.W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Díaz, M.E
Right arrow Articles by Trafford, A.W
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Enhanced sarcolemmal Ca2+ efflux reduces sarcoplasmic reticulum Ca2+ content and systolic Ca2+ in cardiac hypertrophy

M.E Díaz, H.K Graham and A.W Trafford*

Unit of Cardiac Physiology, The University of Manchester, 1.523 Stopford Building, Manchester M13 9PT, UK

* Corresponding author. Tel.: +44-161-275-7969; fax: +44-161-275-2703. Email address: trafford{at}man.ac.uk

Objective: Recent work has identified reductions in the systolic Ca2+ transient in cardiac disease states. The aim of the present study was to identify the mechanisms responsible for perturbations of intracellular calcium homeostasis in isolated cardiac myocytes and determine if such changes can quantitatively explain the reduced systolic Ca2+ transient. Methods: Left ventricular hypertrophy (LVH) was induced by aortic coarctation in adult ferrets. Changes in intracellular Ca2+ regulation, sarcolemmal Ca2+ fluxes and SR function were measured in single left ventricular cardiac myocytes. Results: Cardiac hypertrophy was associated with a 29% increase in action potential duration (APD90); a 48% reduction in the amplitude of and 19% slowing in the rate of decay of the systolic Ca2+ transient; a 20% decrease in SR Ca2+ content and a 36% increase in inward Na+–Ca2+ exchange current for a given change in [Ca2+]i (all P<0.05). Peak L-type Ca2+ current density, integrated Ca2+ influx and SERCA2a protein levels remained unchanged in hypertrophy. By determining the relationship between SR Ca2+ content and systolic Ca2+, the reduction in SR Ca2+ content quantitatively explained the smaller systolic Ca2+ transient. The reduced SR Ca2+ content also accounted for a smaller fractional release of Ca2+ from the SR and lower gain of excitation contraction coupling in cardiac hypertrophy. The increased sarcolemmal-mediated Ca2+ efflux was sufficient to explain the reduction in SR Ca2+ content. Conclusions: The findings indicate that the primary mechanism underlying the smaller systolic Ca2+ transient amplitude in cardiac hypertrophy is decreased SR Ca2+ content occurring as a consequence of reduced SR Ca2+-ATPase-mediated Ca2+ uptake and increased sarcolemmal-mediated Ca2+ efflux from the cell. The increased Na+–Ca2+ exchange-mediated current for a given change in intracellular Ca2+ concentration provides a mechanism for the development of arrhythmias in the face of a reduced SR Ca2+ load in cardiac hypertrophy.

KEYWORDS e-C coupling; Hypertrophy; SR (function); Na/Ca-exchanger; Myocytes


Time for primary review 24 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Mork, I. Sjaastad, O. M. Sejersted, and W. E. Louch
Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1069 - H1079.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Rocchetti, M. Alemanni, G. Mostacciuolo, P. Barassi, C. Altomare, R. Chisci, R. Micheletti, P. Ferrari, and A. Zaza
Modulation of Sarcoplasmic Reticulum Function by PST2744 [Istaroxime; (E,Z)-3-((2-Aminoethoxy)imino) Androstane-6,17-dione Hydrochloride)] in a Pressure-Overload Heart Failure Model
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 957 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. M. Dibb, D. A. Eisner, and A. W. Trafford
Regulation of systolic [Ca2+]i and cellular Ca2+ flux balance in rat ventricular myocytes by SR Ca2+, L-type Ca2+ current and diastolic [Ca2+]i
J. Physiol., December 1, 2007; 585(2): 579 - 592.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.